Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125792821 | 12579282 | 1 | I | 2014 | 20160715 | 20160721 | 20160721 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-46799BP | BOEHRINGER INGELHEIM | 69.13 | YR | F | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125792821 | 12579282 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 508089B | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | |||||
| 125792821 | 12579282 | 2 | C | COREG | CARVEDILOL | 1 | Oral | 2.5 MG | 0 | 1.25 | MG | TABLET | BID | ||||||
| 125792821 | 12579282 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG | 0 | 10 | MG | TABLET | BID | ||||||
| 125792821 | 12579282 | 4 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG | 0 | 75 | MG | TABLET | QD | ||||||
| 125792821 | 12579282 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG | 0 | 300 | MG | TABLET | BID | ||||||
| 125792821 | 12579282 | 6 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | STRENGTH: 70/30 MG; DOSE PER APPLICATION: 35 UNIT IN MORNING;40 UNITS IN AFTERNOON | 0 | ||||||||||
| 125792821 | 12579282 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | TABLET | QD | |||||||||
| 125792821 | 12579282 | 8 | C | XANAX | ALPRAZOLAM | 1 | Oral | STRENGTH: 1 MG; DOSE PER APPLICATION: 1/4 OF A 1 MG TABLET; DAILY DOSE: 3/4 OF A 1 MG TABLET | 0 | TABLET | |||||||||
| 125792821 | 12579282 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG | 0 | 40 | MG | CAPSULE | QD | ||||||
| 125792821 | 12579282 | 10 | C | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 100 MCG | 0 | 50 | UG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125792821 | 12579282 | 1 | Chronic obstructive pulmonary disease |
| 125792821 | 12579282 | 2 | Cardiomyopathy |
| 125792821 | 12579282 | 3 | Hypertension |
| 125792821 | 12579282 | 4 | Transplant dysfunction |
| 125792821 | 12579282 | 5 | Neuralgia |
| 125792821 | 12579282 | 6 | Diabetes mellitus |
| 125792821 | 12579282 | 7 | Product used for unknown indication |
| 125792821 | 12579282 | 8 | Anxiety |
| 125792821 | 12579282 | 9 | Gastrooesophageal reflux disease |
| 125792821 | 12579282 | 10 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125792821 | 12579282 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125792821 | 12579282 | Dizziness | |
| 125792821 | 12579282 | Dyspnoea | |
| 125792821 | 12579282 | Fatigue | |
| 125792821 | 12579282 | Implant site infection | |
| 125792821 | 12579282 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |